IDEAYA Biosciences (IDYA) EBIT Margin (2020 - 2025)
Historic EBIT Margin for IDEAYA Biosciences (IDYA) over the last 6 years, with Q3 2025 value amounting to 52.18%.
- IDEAYA Biosciences' EBIT Margin changed N/A to 52.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 77.97%, marking a year-over-year increase of 56526300.0%. This contributed to the annual value of 4671.07% for FY2024, which is 40962200.0% down from last year.
- As of Q3 2025, IDEAYA Biosciences' EBIT Margin stood at 52.18%.
- In the past 5 years, IDEAYA Biosciences' EBIT Margin registered a high of 52.18% during Q3 2025, and its lowest value of 2059.11% during Q4 2024.
- Over the past 5 years, IDEAYA Biosciences' median EBIT Margin value was 359.01% (recorded in 2022), while the average stood at 494.08%.
- Per our database at Business Quant, IDEAYA Biosciences' EBIT Margin surged by 1327100bps in 2022 and then tumbled by -9903500bps in 2024.
- Quarter analysis of 5 years shows IDEAYA Biosciences' EBIT Margin stood at 620.16% in 2021, then fell by -6bps to 657.46% in 2022, then crashed by -63bps to 1068.77% in 2023, then tumbled by -93bps to 2059.11% in 2024, then skyrocketed by 103bps to 52.18% in 2025.
- Its EBIT Margin was 52.18% in Q3 2025, compared to 2059.11% in Q4 2024 and 1068.77% in Q4 2023.